<DOC>
	<DOCNO>NCT02198456</DOCNO>
	<brief_summary>The aim study intensify follow patient pulmonary arterial hypertension via modern image guided method due consideration possibility three-dimensional echocardiography order optimize specific therapy . The hypothesis increase use modern imaging guide tool essential follow .</brief_summary>
	<brief_title>Imaging Control Study , 3D Echo , MR RHC .</brief_title>
	<detailed_description>It possible perform magnetic resonance imaging patient result echocardiography do screening also follow . The imaging technology make great progress last year enable well assessment haemodynamic parameter day .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<criteria>age &gt; 17 pulmonary arterial hypertension WHO group I go start therapy prostanoid write informed consent Prostanoid naive change pulmonary arterial hypertension therapy within 3 week inclusion study pregnancy lactation period Women childbearing potential use effective secure method birth control severe chronic kidney insufficiency ( glomerular filtration rate &lt; 30 ) , remain 3 month liver insufficiency Child C life expectancy short course study ( example malignant disease )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>pulmonary arterial hypertension</keyword>
</DOC>